Kristiina Waehaelae

Title: The Innovations of Kristiina Waehaelae

Introduction

Kristiina Waehaelae is a notable inventor based in Helsinki, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target steroid hormone-dependent disorders. Her work is characterized by a commitment to advancing therapeutic options for patients.

Latest Patents

Waehaelae holds a patent for "Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase." This patent focuses on thiophenepyrimidinone compounds that are useful in therapy, especially for the treatment and prevention of steroid hormone-dependent diseases. The compounds specifically inhibit the 17β-hydroxysteroid dehydrogenase enzymes, which play a crucial role in various hormonal processes.

Career Highlights

Kristiina Waehaelae has built her career at Solvay Pharmaceuticals B.V., where she has been instrumental in research and development. Her innovative approach has led to advancements in the pharmaceutical industry, particularly in the area of hormone-related therapies.

Collaborations

Waehaelae has collaborated with several talented individuals, including Annamaria Lilienkampf and Sari Alho. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kristiina Waehaelae's contributions to the field of pharmaceuticals through her innovative patents and collaborative efforts highlight her importance as an inventor. Her work continues to pave the way for new therapeutic options in treating hormone-dependent disorders.